Allen-Bradley 20G11NB022JA0NNNNN

The part number 20G11NB022JA0NNNNN is linked to various research initiatives rather than technical specifications. It is associated with projects funded by reputable organizations, including the National Science Foundation (NSF) and the National Institutes of Health (NIH). One notable NSF project, titled "EAGER GERMINATION Collaborative Research," focuses on enhancing the ability of academic researchers to generate meaningful research questions through innovative pedagogical methods. Similarly, the NIH has supported projects under the "Building Blocks, Biological Pathways and Networks" program that investigate crucial biological mechanisms, including lysine modifications and proteolytic pathways. Additionally, clinical trials documented on ClinicalTrials.gov examine the safety and effectiveness of treatments like semaglutide in relation to obesity management. The G12/MBRC program is another significant NIH endeavor aimed at empowering minority-serving medical institutions to advance their research capabilities. Overall, this part number reflects a commitment to fostering significant advancements in various fields through targeted research efforts.